How much is Aloe Therapeutics worth in 2026?

Aloe Therapeutics has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Aloe Therapeutics raised?

Aloe Therapeutics has raised N/A in total funding across 1 funding rounds.

Aloe Therapeutics

Other Pharmaceuticals and Biotechnology

Aloe Therapeutics valuation and funding history | Last updated: September 18, 2024 | 1 funding rounds

Current Valuation

N/A

As of September 18, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Sep 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 18, 2024	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Aloe Therapeutics is currently valued at N/A as of September 18, 2024.

Track Aloe Therapeutics Valuation Updates

Get notified when Aloe Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Aloe Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Aloe Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Aloe Therapeutics Worth in 2026?

Aloe Therapeutics is a leading private company in the Other Pharmaceuticals and Biotechnology sector. Track Aloe Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Aloe Therapeutics Valuation is Determined

Private company valuations like Aloe Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.